跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,098 条关于
“serum tryptase”
全部
4,098
临床试验
3,120
药物
147
机构
12
资讯
819
去年
Bezuclastinib Shows Strong Symptom and Biomarker Improvement in Non-Advanced Systemic Mastocytosis
去年
Jasper Therapeutics' Briquilimab Shows Promise in Chronic Spontaneous Urticaria
去年
Third Harmonic Bio's THB335 Shows Promising Phase 1 Results for Chronic Urticaria Treatment
3个月前
Celldex's Bispecific CDX-622 Shows Rapid Mast Cell Depletion and Favorable Safety in First-in-Human Phase 1 Trial
去年
Third Harmonic Bio Stockholders Approve Liquidation Plan as THB335 Shows 85% Tryptase Reduction in Phase 1 Trial
去年
Blueprint Medicines' BLU-808 Shows Superior Profile Over Third Harmonic's THB001 in KIT Inhibitor Race
去年
Cogent Biosciences' Bezuclastinib Shows Promise in Systemic Mastocytosis Trials
去年
Blueprint Medicines Announces Positive BLU-808 Phase 1 Data and 2025 Growth Strategy
去年
Bezuclastinib Achieves 87% Response Rate in Pivotal Trial for Non-Advanced Systemic Mastocytosis
去年
Tryptase Inhibitor Fails to Meet Primary Endpoint in Asthma Exacerbation Trial
第 1 页,共 82 页
上一页
下一页